These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19295485)

  • 1. Effects of carvedilol on mortality and inflammatory responses to severe hemorrhagic shock in rats.
    Taniguchi T; Kurita A; Yamamoto K; Inaba H
    Shock; 2009 Sep; 32(3):272-5. PubMed ID: 19295485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of carvedilol administration on cardiopulmonary resuscitation in a rat model of cardiac arrest induced by airway obstruction.
    Kurita A; Taniguchi T; Yamamoto K
    Anesth Analg; 2010 Nov; 111(5):1207-10. PubMed ID: 20705786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carvedilol, a new beta-adrenoreceptor blocker, vasodilator and free-radical scavenger, exerts an anti-shock and endothelial protective effect in rat splanchnic ischemia and reperfusion.
    Christopher TA; Lopez BL; Yue TL; Feuerstein GZ; Ruffolo RR; Ma XL
    J Pharmacol Exp Ther; 1995 Apr; 273(1):64-71. PubMed ID: 7714814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.
    Barone FC; Nelson AH; Ohlstein EH; Willette RN; Sealey JE; Laragh JH; Campbell WG; Feuerstein GZ
    J Pharmacol Exp Ther; 1996 Nov; 279(2):948-55. PubMed ID: 8930204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
    Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
    J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotection by Carvedilol: antiapoptosis is independent of beta-adrenoceptor blockage in the rat heart.
    Schwarz ER; Kersting PH; Reffelmann T; Meven DA; Al-Dashti R; Skobel EC; Klosterhalfen B; Hanrath P
    J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):207-15. PubMed ID: 14506546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients.
    Leonetti G; Sampieri L; Cuspidi C; Boselli L; Terzoli L; Rupoli L; Zanchetti A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S94-6. PubMed ID: 2454377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of capsaicin-sensitive sensory neurons by carvedilol, a nonselective beta-blocker, in spontaneous hypertensive rats.
    Okajima K; Harada N; Uchiba M; Isobe H
    J Pharmacol Exp Ther; 2004 May; 309(2):684-91. PubMed ID: 14764656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke.
    Savitz SI; Erhardt JA; Anthony JV; Gupta G; Li X; Barone FC; Rosenbaum DM
    J Cereb Blood Flow Metab; 2000 Aug; 20(8):1197-204. PubMed ID: 10950380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol, a nonselective beta-blocker, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro.
    Mizuochi Y; Okajima K; Harada N; Molor-Erdene P; Uchiba M; Komura H; Tsuda T; Katsuya H
    Transl Res; 2007 Apr; 149(4):223-30. PubMed ID: 17383596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the novel multiple-action agent carvedilol on severe nephrosclerosis in renal ablated rats.
    Rodriguez-Perez JC; Losada A; Anabitarte A; Cabrera J; Llobet J; Palop L; Plaza C
    J Pharmacol Exp Ther; 1997 Oct; 283(1):336-44. PubMed ID: 9336341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influences of carvedilol treatment on the effects of acetylcholine on regional haemodynamics in the spontaneously hypertensive rat.
    Granstam SO; Fellström B; Lind L
    Clin Sci (Lond); 1998 Sep; 95(3):303-9. PubMed ID: 9730849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of carvedilol infusion and the contribution of the sympathetic nervous system in rats with heart failure.
    Abe Y; Watanabe K; Sato S; Nagai Y; Kamal FA; Wahed MI; Wen J; Narasimman G; Ma M; Suresh P; Takahashi T; Tachikawa H; Kashimura T; Tanabe N; Kodama M; Aizawa Y; Yamaguchi K; Miyazaki M; Kakemi M
    Pharmacology; 2004 Dec; 72(4):213-9. PubMed ID: 15539880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of carvedilol a nonselective beta-blocker on portal hemodynamics in cirrhosis.
    Fierbinteanu-Braticevici C; Udeanu M; Dragomir P; Andronescu D
    Rom J Intern Med; 2003; 41(3):247-54. PubMed ID: 15526508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of interleukin-10 in hemorrhagic shock.
    Karakozis S; Hinds M; Cook JW; Kim D; Provido H; Kirkpatrick JR
    J Surg Res; 2000 May; 90(2):109-12. PubMed ID: 10792949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of adrenoceptor blocking drugs on cardiovascular responsiveness to passive orthostasis: a placebo-controlled double-blind study.
    Nieminen T; Ylitalo R; Kööbi T; Ylitalo P; Kähönen M
    Arzneimittelforschung; 2005; 55(4):205-11. PubMed ID: 15901043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
    Hanada K; Asari K; Saito M; Kawana J; Mita M; Ogata H
    Eur J Pharmacol; 2008 Jul; 589(1-3):194-200. PubMed ID: 18534575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemia.
    Hashimoto H; Kanda A; Hubo H; Tanaka M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S22-8. PubMed ID: 1721975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
    Al-Hesayen A; Azevedo ER; Floras JS; Hollingshead S; Lopaschuk GD; Parker JD
    Eur J Heart Fail; 2005 Jun; 7(4):618-23. PubMed ID: 15921803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P; Omvik P; Nordrehaug JE; White W
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.